Table 4.
Variables | Adjusted HR∗ | 95% CI | P-value |
Anticoagulant | 2.87 | 0.16–50.61 | .471 |
Antiplatelet | 1.71 | 0.20–14.49 | .625 |
Anti-VEGF† | |||
0 | 1.00 | ||
1 | 0.28 | 0.01–8.36 | .461 |
2 | 0.63 | 0.26–15.26 | .776 |
≥3 | 0.36 | 0.48–2.63 | .311 |
Variables | Adjusted HR∗ | 95% CI | P-value |
Anticoagulant | 2.87 | 0.16–50.61 | .471 |
Antiplatelet | 1.71 | 0.20–14.49 | .625 |
Anti-VEGF† | |||
0 | 1.00 | ||
1 | 0.28 | 0.01–8.36 | .461 |
2 | 0.63 | 0.26–15.26 | .776 |
≥3 | 0.36 | 0.48–2.63 | .311 |